No disclosed relationships extracted for KTTAyet. The EDGAR pass hasn't reached this filing; the graph grows as filings are read.
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Nothing on the wire mentions KTTA yet. Iris sweeps the public feeds every quarter hour; headlines land here the moment a sweep tags them.
How KTTA has moved on past release days vs its typical ±4.3% day, and how often it closed up. Computed from daily closes — not a forecast.